Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

Breast Cancer Research and Treatment

Volumn 79, Issue 3, 2003, Pages 379-390

  Helguero, Luisa A ^a   Viegas, Marcelo ^a   Asaithamby, Aroumougame ^b   Shyamala, Gopalan ^b   Lanari, Claudia ^a   Molinolo, Alfredo A ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hormone dependence; Hormone response; Immunohistochemistry; Mammary carcinomas; Mice; Progesterone receptor isoforms; Western blot

Indexed keywords

ANTIGESTAGEN; CARCINOGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER MODEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; HORMONE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, DUCTAL, BREAST; DOWN-REGULATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED BALB C; PROGESTERONE CONGENERS; PROGESTINS; RECEPTORS, PROGESTERONE; RNA;

EID: 0037899633     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024029826248     Document Type: Article

References (48)

1. Harris JR, Lippman ME, Veronesi U. Willett W: Breast cancer (1). N Engl J Med 327: 319-328, 1992
2. Tonetti DA, Jordan VC: Possible mechanisms in the emergence of tamoxifen-resistant breast cancer. Anticancer Drugs 6: 498-507, 1995
3. Clarke R, Brünner N: Acquired estrogen independence and antiestrogen resistance in breast cancer. Estrogen receptor driven phenotypes?. Trends Endocrinol Metabiol 7: 291-301, 1996
4. Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92: 328-332, 2000
5. Women's Health Initiative: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002
6. Tsai MJ, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486, 1994
7. Beato M: Transcriptional control by nuclear receptors. FASEB J 5: 2044-2051, 1991
8. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 10: 1167-1177, 1996
9. Horwitz KB, Wei LL, Francis MD: Structural analyses of progesterone receptors. J Steroid Biochem 24: 109-117, 1986
10. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14: 8356-8364, 1994
11. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277: 5209-5218, 2002
12. Lessey BA, Alexander PS, Horwitz KB: The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling. Endocrinology 112: 1267-1274, 1983
13. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL: Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55: 5063-5068, 1995
14. Bamberger AM, Milde-Langosch K, Schulte HM, Loning T: Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors. Horm Res 54: 32-37, 2000
15. Shyamala G, Schneider W, Schott D: Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 126: 2882-2889, 1990
16. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G: Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J Steroid Biochem Mol Biol 38: 285-291, 1991
17. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E: Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 95: 696-701, 1998
18. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM: Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289: 1751-1754, 2000
19. Lanari C, Molinolo AA, Pasqualini CD: Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett 33: 215-223, 1986
20. Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD: Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J Natl Cancer Inst 79: 1341-1350, 1987
21. Kordon E, Lanari C, Molinolo AA, Elizalde PV, Charreau EH, Pasqualini CD: Estrogen inhibition of MPA-induced mouse mammary tumor transplants. Int J Cancer 49: 900-905, 1991
22. Kordon EC, Molinolo AA, Pasqualini CD, Charreau EH, Pazos P, Dran G, Lanari C: Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology. Breast Cancer Res Treat 28: 29-39, 1993
23. Kordon E, Lanari C, Meiss R, Charreau E, Pasqualini CD: Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast Cancer Res Treat 17: 33-43, 1990
24. Montecchia MF, Lamb C, Molinolo AA, Luthy IA, Pazos P, Charreau E, Vanzulli S, Lanari C: Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas. J Steroid Biochem Mol Biol 68: 11-21, 1999
25. Costa SD, Lange S, Klinga K, Merkle E, Kaufmann M: Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer - results of the analysis of 670 patients with 11 years of follow-up. Eur J Cancer 38: 1329-1334, 2002
26. Institute of Laboratory Animal Resources, Commission on Life Sciences National Research Council: Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, 1996.
27. Lanari C, Kordon E, Molinolo A, Pasqualini CD, Charreau EH: Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. Int J Cancer 43: 845-850, 1989
28. Kordon EC, Guerra F, Molinolo AA, Charreau EH, Pasqualini CD, Pazos P, Dran G, Lanari C: Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content. Int J Cancer 59: 196-203, 1994
29. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr. CA, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9: 2266-2278, 1995
30. Lowry OH, Rosebrough NJ, Farr AL: Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
31. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
32. Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, Ohlsson-Wilhelm BM, Satyaswaroop PG: Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 121: 1123-1132, 1987
33. Yeates C, Hunt SM, Balleine RL, and Clarke CL: Characterization of a truncated progesterone receptor protein in breast tumors. J Clin Endocrinol Metabiol 83: 4600-4607, 1998
34. Shyamala G, Barcellos-Hoff MH, Toft D, Yang X: In situ localization of progesterone receptors in normal mouse mammary glands: absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium. J Steroid Biochem Mol Biol 63: 251-259, 1997
35. Silberstein GB, Van Horn K, Shyamala G, Daniel CW: Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. Cell Growth Diff 7: 945-952, 1996
36. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
37. Schott DR, Shyamala G, Schneider W, Parry G: Molecular cloning, sequence analyses, and expression of complementary DNA encoding routine progesterone receptor. Biochemistry 30: 7014-7020, 1991
38. Weigel NL: Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319: 657-667, 1996
39. Palmieri C, Cheng GJ, Sajl S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA: Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9: 1-13, 2002
40. Castoria G, Migliaccio A, Bilancio A, Pagano M, Abbondanza C, Auricchio F: A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers. Int J Cancer 65: 574-583, 1996
41. Migliaccio A, Pagano M, de Goeij CC, Di Domenico M, Castoria G, Sluyser M, Auricchio F: Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors. Int J Cancer 51: 733-739, 1992
42. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL: Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat 54: 117-122, 1999
43. Brunner N, Spang-Thomsen M, Cullen K: The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer. Breast Cancer Res Treat 39: 87-92, 1996
44. Chisamore MJ, Ahmed Y, Bentrem DJ, Jordan VC, Tonetti DA: Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha. Clin Cancer Res 7: 3156-3165, 2001
45. Levenson AS, Jordan VC: Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem Mol Biol 51: 229-239, 1994
46. Zajchowski DA, Sager R, Webster L: Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53: 5004-5011, 1993
47. Lantinga-van Leeuwen IS, van Garderen E, Rutteman GR, Mol JA: Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. J Steroid Biochem Mol Biol 75: 219-228, 2000
48. Lamb C, Simian M, Molinolo A, Pazos P, Lanari C: Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation. J Steroid Biochem Mol Biol 70: 133-142, 1999